Literature DB >> 17495272

QT interval analysis in patients with chronic liver disease: a prospective study.

Feridun Kosar1, Fehmi Ates, Ibrahim Sahin, Melih Karincaoglu, Bulent Yildirim.   

Abstract

In previous studies, it has been shown that QT interval prolongation is related to an increased mortality rate in chronic liver disease (CLD). But QT dispersion (QTd) and its clinical significance in CLD has not been well studied. The objectives of this study were to investigate the relation between QTd and severity of the disease and determine its prognostic value in cirrhotic patients. Thirty-three consecutive patients with cirrhosis and 35 sex- and age-matched healthy subjects were studied. QT intervals and QT dispersions were measured on admission, and all intervals were corrected for heart rate according to Bazett's formula. The authors analyzed the potential relationship between QT parameters and the disease severity according to Child-Pugh classification and compared these values between survivors and nonsurvivors after a 3-year follow-up. Child-Pugh classification is used to assess liver function in cirrhosis. Corrected QT (QTc) prolongations were found in 32% of patients with cirrhosis and 5.7% of the healthy controls (p <0.001). The prevalence of increased (>70 ms) corrected QT dispersion (QTcd) was 45% in patients with cirrhosis. According to Child-Pugh criteria: QTd, maximum QT interval (QTmax), corrected QTmax (QTcmax), and QTcd in class C were significantly higher than those of class A and B (p <0.05, for all comparison). But there was no significant difference between class A and B in QTmax, QTcmax, QTd, and QTcd. There were 10 (30%) deaths from all causes during 3-year follow-up in the study group. Cox regression analysis showed that QTd and QTcd were better mortality indicators than QTmax and QTcmax, and Child's classification was the best predictor for mortality among all variables. In conclusion, QT dispersion and corrected QT dispersion parameters were better mortality indicators than other QT interval parameters and also may give additional prognostic information in patients with chronic liver disease.

Entities:  

Mesh:

Year:  2007        PMID: 17495272     DOI: 10.1177/0003319707300368

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  12 in total

Review 1.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

2.  Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study.

Authors:  Lorena Puchades; Stephanie Chau; John A Dodson; Yara Mohamad; Rachel Mustain; Adrienne Lebsack; Victoria Aguilera; Martin Prieto; Jennifer C Lai
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

3.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

Review 4.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

5.  Partners in crime in the setting of recurring cardiac arrest.

Authors:  Lida P Papavasileiou; Giovanni B Forleo; Luca Santini; Eugenio Martuscelli; Francesco Romeo
Journal:  Cardiol Res Pract       Date:  2011-03-03       Impact factor: 1.866

6.  Torsade de pointes in liver transplantation recipient after induction of general anesthesia: a case report.

Authors:  Eun-Jin Chung; Yun-Seok Jeon; Hyun-Joo Kim; Kook Hyun Lee; Ji-Won Lee; Kyoung-Ah Han; Seung-Hwan Jung
Journal:  Korean J Anesthesiol       Date:  2014-01-28

7.  Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study.

Authors:  Sheng-Jie Wu; Hua-Dong Yan; Zai-Xing Zheng; Ke-Qing Shi; Fa-Ling Wu; Yao-Yao Xie; Yu-Chen Fan; Bo-Zhi Ye; Wei-Jian Huang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

8.  Heart rate-corrected QT interval helps predict mortality after intentional organophosphate poisoning.

Authors:  Shou-Hsuan Liu; Ja-Liang Lin; Cheng-Hao Weng; Huang-Yu Yang; Ching-Wei Hsu; Kuan-Hsing Chen; Wen-Hung Huang; Tzung-Hai Yen
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis.

Authors:  Axel Josefsson; Michael Fu; Einar Björnsson; Evangelos Kalaitzakis
Journal:  BMC Gastroenterol       Date:  2014-04-05       Impact factor: 3.067

10.  QT prolongation is associated with increased mortality in end stage liver disease.

Authors:  Sun Moon Kim; Bennet George; Diego Alcivar-Franco; Charles L Campbell; Richard Charnigo; Brian Delisle; Jonathan Hundley; Yousef Darrat; Gustavo Morales; Samy-Claude Elayi; Alison L Bailey
Journal:  World J Cardiol       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.